Results 41 to 50 of about 327,982 (244)

The First Case of Concomitant Mycobacterium genavense lymphadenitis and EBV-positive lymphoproliferative disorder

Mediterranean Journal of Hematology and Infectious Diseases, 2020
This is the first case of concurrent Mycobacterium genavense lymphadenitis and Epstein-Barr virus (EBV)-positive lymphoproliferative disorder (LPD) in the same lymph node with no immunocompromised history. M.
Yusuke Ito, Kensuke Takaoka, Kazuhiro Toyama, Yoshitaka Wakabayashi, Aya Shinozaki-Ushiku, Aiko Okazaki, Kinuyo Chikamatsu, Satoshi Mitarai, Tetsuo Ushiku, Mineo Kurokawa   +9 more
doaj   +1 more source

Microevolution ofMycobacterium tuberculosisin a Tuberculosis Patient [PDF]

Journal of Clinical Microbiology, 2010
ABSTRACTFiveMycobacterium tuberculosisisolates were obtained from three body sites from a Dutch patient. The isolates displayed a single genotype by 24-locus MIRU-VNTR typing (except for a single locus not amplified from one isolate) but were differentiated by small variations in IS6110fingerprints, spoligotypes, 6 hypervariable MIRU-VNTR loci, and/or ...
Al-Hajoj, SAM, Akkerman, O, Parwati, I, Al-Gamdi, S, Rahim, Z, van Soolingen, D, van Ingen, J, Supply, P, van der Zanden, AGM   +8 more
openaire   +5 more sources

Structures of mycobacterial 3‐methylcrotonyl‐CoA carboxylase reveal carrier‐domain translocation between catalytic sites

FEBS Letters, EarlyView.
Mycobacterial 3‐methylcrotonyl‐CoA carboxylase uses a mobile biotin‐carrying domain to shuttle a carboxyl group between two catalytic sites, enabling carboxylation of 3‐methylcrotonyl‐CoA during leucine breakdown. Cryo‐electron microscopy captures the carrier at both sites and reveals an inward loop movement that may prevent futile rebinding to the ...
Ajit Yadav, Bogdan I. Florea, Sebastian Geibel   +2 more
wiley   +1 more source

Mycobacterium tuberculosis is less likely to acquire pathogenic mutations during latent infection than during active disease

Microbiology Spectrum
Most people infected with Mycobacterium tuberculosis (Mtb) are believed to be in a state of latent tuberculosis (TB) infection (LTBI). Although LTBI is asymptomatic and not infectious, there is a risk of developing active disease even decades after ...
Asami Osugi, Aki Tamaru, Takashi Yoshiyama, Tomotada Iwamoto, Satoshi Mitarai, Yoshiro Murase   +5 more
doaj   +1 more source

Aktivitas Anti Mycobacterium tuberculosis Strain H37Rv dan MDR (Multi Drug Resistant) dari Ekstrak Rimpang Curcuma mangga Val.

Jurnal Farmasi Galenika (Galenika Journal of Pharmacy), 2020
TB is an infectious disease caused by the bacterium Mycobacterium tuberculosis. Empirically the plants that have long been used in medicine are Curcuma mangga  rhizome, which shows pharmacological activity as an anti Mycobacterium tuberculosis drug.
Ritha Pratiwi, Gemini Alam, Herlina Rante, Nasrum Massi   +3 more
doaj   +1 more source

Interference of Mycobacterium tuberculosis with macrophage responses [PDF]

, 2009
Tuberculosis, caused by Mycobacterium tuberculosis, has become an important health and economic burden, with more than four thousand people succumbing to the disease every day.
Pieters, J., Mueller, P., Scherr, N., Jayachandran, R.   +3 more
core  

Predictive and prognostic biomarkers of Bacillus Calmette‐Guérin therapy failure in bladder cancer patients: A systematic review

Molecular Oncology, EarlyView.
High‐risk bladder cancer is typically treated with Bacillus Calmette‐Guérin (BCG), but 30–40% of patients relapse. No FDA‐ or CE‐approved biomarkers currently predict or prognosticate BCG failure. We systematically reviewed the literature and identified 72 eligible studies, revealing several promising biomarkers associated with BCG treatment response ...
Rui Ribeiro‐Pereira, Ana Teixeira‐Marques, Rui Freitas, João A Carvalho, Sara Monteiro‐Reis, Giorgio I. Russo, Rui Henrique, Carmen Jerónimo   +7 more
wiley   +1 more source

Risk factors, molecular analysis and treatment outcomes of amikacin-resistant Mycobacterium avium complex pulmonary disease

ERJ Open Research
Background Although the incidence of amikacin (AMK)-resistant Mycobacterium avium complex (MAC) pulmonary disease (PD) is suspected to have increased, limited data are available on AMK-resistant MAC-PD.
Tatsuya Kodama, Akio Aono, Keiji Fujiwara, Koji Furuuchi, Masashi Ito, Keisuke Kamada, Fumiya Watanabe, Kinuyo Chikamatsu, Yuriko Igarashi, Yoshiro Murase, Hideo Ogata, Yuji Shiraishi, Takashi Yoshiyama, Ken Ohta, Satoshi Mitarai, Kozo Morimoto   +15 more
doaj   +1 more source

Mycobacterium tuberculosis Metabolism [PDF]

Cold Spring Harbor Perspectives in Medicine, 2014
Metabolism underpins the physiology and pathogenesis of Mycobacterium tuberculosis. However, although experimental mycobacteriology has provided key insights into the metabolic pathways that are essential for survival and pathogenesis, determining the metabolic status of bacilli during different stages of infection and in different cellular ...
openaire   +2 more sources

PolyTB: a genomic variation map for Mycobacterium tuberculosis [PDF]

, 2014
Tuberculosis (TB) caused by Mycobacterium tuberculosis (Mtb) is the second major cause of death from an infectious disease worldwide. Recent advances in DNA sequencing are leading to the ability to generate whole genome information in clinical isolates ...
Gagneux, S., Perdigão, João, McNerney, R., Glynn, Judith R., McNerney, Ruth, Preston, M., Perdigao, J., Gagneux, Sebastien, Viveiros, M., Glynn, Judith R, Guerra-Assunção, José Afonso, Glynn, J., Parkhill, J., Harris, D., Clark, T., Coll, Francesc, Viveiros, Miguel, Hill-Cawthorne, G., Hill-Cawthorn, Grant, Pain, A., Pain, Arnab, Clark, Taane G., Portugal, I., Parkhill, Julian, Preston, Mark, Drobniewski, Francis, Drobniewski, F., Portugal, Isabel, Martin, Nigel, Guerra-Assuncao, J., Harris, David, Coll, F., Clark, Taane G   +32 more
core   +1 more source